Terms: = Pancreatic cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Clinical Outcome
164 results:
1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
2. Locally advanced pancreatic cancer: Is surgical palliation associated with improved clinical outcome relative to medical palliation?
Kramer SP; Tonelli C; Luchette FA; Swanson J; Abdelsattar Z; Cohn T; Baker MS
Am J Surg; 2024 Apr; 230():73-77. PubMed ID: 38350746
[TBL] [Abstract] [Full Text] [Related]
3. Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma.
Tao Q; Lang Z; Li Y; Gao Y; Lin L; Yu Z; Zheng J; Yu S
BMC Cancer; 2023 Oct; 23(1):1029. PubMed ID: 37875823
[TBL] [Abstract] [Full Text] [Related]
4. Optimal Follow-up of Incidental pancreatic Cystic Lesions without Worrisome Features: clinical outcome after Long-term Follow-up.
Ahn DW; Lee SH; Choi JH; Cho IR; Jang DK; Paik WH; Jeong JB; Ryu JK; Kim YT
Gut Liver; 2024 Mar; 18(2):328-337. PubMed ID: 37840221
[TBL] [Abstract] [Full Text] [Related]
5. Response of Locally Advanced pancreatic cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and clinical outcome.
Sharma NR; Lo SK; Hendifar A; Othman MO; Patel K; Mendoza-Ladd A; Verco S; Maulhardt HA; Verco J; Wendt A; Marin A; Schmidt CM; diZerega G
Pancreas; 2023 Mar; 52(3):e179-e187. PubMed ID: 37782888
[TBL] [Abstract] [Full Text] [Related]
6. Real time
Kim DW; Beato F; Kim Y; Tassielli AF; Dai R; Denbo JW; Hodul PJ; Malafa MP; Fleming JB
Oncotarget; 2023 Sep; 14():811-818. PubMed ID: 37713330
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of perioperative serum low-density lipoprotein cholesterol level for postoperative prognosis of pancreatic cancer: a retrospective study.
Wang H; Li Y; Huang J; Ma Y; Lyu S; Lang R
Lipids Health Dis; 2023 Jun; 22(1):88. PubMed ID: 37391827
[TBL] [Abstract] [Full Text] [Related]
8. The Feasibility, Proficiency, and Mastery Learning Curves in 635 Robotic Pancreatoduodenectomies Following a Multicenter Training Program: "Standing on the Shoulders of Giants".
Zwart MJW; van den Broek B; de Graaf N; Suurmeijer JA; Augustinus S; Te Riele WW; van Santvoort HC; Hagendoorn J; Borel Rinkes IHM; van Dam JL; Takagi K; Tran KTC; Schreinemakers J; van der Schelling G; Wijsman JH; de Wilde RF; Festen S; Daams F; Luyer MD; de Hingh IHJT; Mieog JSD; Bonsing BA; Lips DJ; Abu Hilal M; Busch OR; Saint-Marc O; Zeh HJ; Zureikat AH; Hogg ME; Koerkamp BG; Molenaar IQ; Besselink MG;
Ann Surg; 2023 Dec; 278(6):e1232-e1241. PubMed ID: 37288547
[TBL] [Abstract] [Full Text] [Related]
9. Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer.
Inkoom A; Ndemazie NB; Smith T; Frimpong E; Bulusu R; Poku R; Zhu X; Han B; Trevino J; Agyare E
BMC Cancer; 2023 May; 23(1):435. PubMed ID: 37179357
[TBL] [Abstract] [Full Text] [Related]
10. A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation.
Yang Z; Xie H; Wan J; Wang Y; Zhang L; Zhou K; Tang H; Zhao W; Wang H; Song P; Zheng S
EBioMedicine; 2023 Jun; 92():104594. PubMed ID: 37167784
[TBL] [Abstract] [Full Text] [Related]
11. Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart review.
Haidar M; Al Mahmasani L; Chehade L; Elias C; El Jebai M; Temraz S; Charafeddine M; Al Darazi M; Shamseddine A
Nucl Med Commun; 2023 Jun; 44(6):471-479. PubMed ID: 36897058
[TBL] [Abstract] [Full Text] [Related]
12. [clinical outcome of Robot-Assisted Distal Pancreatectomy in Our Institutional Introduction].
Matsukawa H; Satoh D; Ishida M; Yoshimoto M; Idani H; Shirakawa Y; Nakano K; Yoshimitsu M; Choda Y; Yano T; Sawada H; Katsura Y; Okura T; Fukuhara S; Shiozaki S
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1671-1672. PubMed ID: 36733171
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcome and Treatment Sequences of Patients with Advanced pancreatic cancer Treated with Contemporary Chemotherapy Protocols.
Roehrle J; Kasper S; Treckmann JW; Markus P; Schumacher B; Albers D; Wendling J; Ting S; Mende B; Maßmann M; Markus M; Virchow I; Rosery V; Laue K; Zaun G; Kostbade K; Pogorzelski M; Reissig TM; Liffers ST; Schmid K; Schildhaus HU; Schuler M; Siveke JT; Wiesweg M
Oncol Res Treat; 2023; 46(4):140-150. PubMed ID: 36720216
[TBL] [Abstract] [Full Text] [Related]
14. outcomes of feeding jejunostomy after pancreaticoduodenectomy: A single-center experience.
Yamamoto N; Aoyama T; Murakawa M; Kamiya M; Shiozawa M; Rino Y; Masuda M; Morinaga S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S444-S448. PubMed ID: 36511001
[TBL] [Abstract] [Full Text] [Related]
15. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
Schipper LJ; Samsom KG; Snaebjornsson P; Battaglia T; Bosch LJW; Lalezari F; Priestley P; Shale C; van den Broek AJ; Jacobs N; Roepman P; van der Hoeven JJM; Steeghs N; Vollebergh MA; Marchetti S; Cuppen E; Meijer GA; Voest EE; Monkhorst K
ESMO Open; 2022 Dec; 7(6):100611. PubMed ID: 36463731
[TBL] [Abstract] [Full Text] [Related]
16. Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with prostate cancer.
Bakker A; Slack JC; Palanisamy N; Carskadon S; Ghosh S; Khalifeh I; Bismar TA
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3721-3728. PubMed ID: 35982181
[TBL] [Abstract] [Full Text] [Related]
17. clinical outcomes of endoscopic papillectomy of ampullary adenoma: A multi-center study.
Choi SJ; Lee HS; Kim J; Choe JW; Lee JM; Hyun JJ; Yoon JH; Kim HJ; Kim JS; Choi HS
World J Gastroenterol; 2022 May; 28(17):1845-1859. PubMed ID: 35633905
[TBL] [Abstract] [Full Text] [Related]
18. Impact of Modern Management Strategies on the clinical outcome of Patients With Low Rectal cancer - A Retrospective, Monocentric Cohort Study.
Karam E; Sindayigaya R; Giger-Pabst U; Gabriel M; Michot N; Courtot L; Tabchouri N; Moussata D; Lecomte T; Chapet S; Calais G; Bourlier P; Salamé E; Ouaissi M
Anticancer Res; 2022 Apr; 42(4):1949-1963. PubMed ID: 35347015
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma.
Ji R; Ng KK; Chen W; Yang W; Zhu H; Cheung TT; Chiang CL; Wong TCL; Kong FM; Wu G; Lo CM
Medicine (Baltimore); 2022 Jan; 101(4):e28545. PubMed ID: 35089192
[TBL] [Abstract] [Full Text] [Related]
20. [Short-Term clinical outcome of Robotic Surgery for Advanced Rectal cancer after Neoadjuvant Therapy].
Aomatsu N; Maeda K; Nishii T; Tachimori A; Fukui Y; Kuroda K; Nishimura J; Tashima T; Murata A; Sakurai K; Kodai S; Tamamori Y; Kubo N; Shimizu S; Kanazawa A
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2091-2093. PubMed ID: 35045503
[TBL] [Abstract] [Full Text] [Related]
[Next]
